Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.

A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...

NIH researchers identified MAD21-101, a novel antibody targeting a previously unexplored epitope on the malaria parasite.

The malaria parasite, Plasmodium falciparum, however, is an entirely more challenging pathogen because it is such a large and complex organism compared to a virus. At the Proteo-Science Center at ...

Nearly half the world's population lives in regions where malaria is endemic, with the parasite Plasmodium falciparum accounting for approximately 95% of malaria-related deaths globally.Now, a new ...

NIH researchers discover novel class of antibodies that could lead to next generation of interventions against malaria.

The vaccine employs a weakened strain of Plasmodium falciparum (P falciparum), the parasite that causes the deadliest form of malaria in humans. “We have removed an important gene in the malaria ...

More than 60% of rapid diagnostic tests were positive for malaria, and about two-thirds of those tested with a more precise PCR laboratory test were also positive for Plasmodium falciparum ...

New antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody ...

More than 60% of rapid diagnostic tests were positive for malaria, and about two-thirds of those tested with a more precise ...